Literature DB >> 18177747

Antibacterial actions of secreted phospholipases A2. Review.

Timo J Nevalainen1, Garry G Graham, Kieran F Scott.   

Abstract

Antibacterial properties of secreted phospholipases A2 (PLA2) have emerged gradually. Group (G) IIA PLA2 is the most potent among mammalian secreted (s) PLA2s against Gram-positive bacteria, but additional antibacterial compounds, e.g. the bactericidal/permeability-increasing protein, are needed to kill Gram-negative bacteria. The mechanisms of binding to the bacterial surface and the killing of bacteria by sPLA2s are based on the positive charge of the PLA2 protein and its phospholipolytic enzymatic activity, respectively. The concentration of GIIA PLA2 is highly elevated in serum of patients with bacterial sepsis, and overexpression of GIIA PLA(2) protects transgenic mice against experimental Gram-positive infection. The synthesis and secretion of GIIA PLA2 are stimulated by the cytokines TNF-alpha, IL-1 and IL-6. Secreted PLA2s may be potentially useful new endogenous antibiotics to combat infections including those caused by antibiotic-resistant bacteria such as methicillin-resistant staphylococci and vancomysin-resistant enterococci.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18177747     DOI: 10.1016/j.bbalip.2007.12.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  58 in total

Review 1.  The gastrointestinal immune system: Implications for the surgical patient.

Authors:  Joseph F Pierre; Rebecca A Busch; Kenneth A Kudsk
Journal:  Curr Probl Surg       Date:  2015-10-23       Impact factor: 1.909

Review 2.  Antimicrobial compounds in tears.

Authors:  Alison M McDermott
Journal:  Exp Eye Res       Date:  2013-07-20       Impact factor: 3.467

Review 3.  Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis.

Authors:  Charles L Bevins; Nita H Salzman
Journal:  Nat Rev Microbiol       Date:  2011-03-22       Impact factor: 60.633

Review 4.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

Review 5.  Inflammatory bowel disease: an impaired barrier disease.

Authors:  Simon Jäger; Eduard F Stange; Jan Wehkamp
Journal:  Langenbecks Arch Surg       Date:  2012-11-18       Impact factor: 3.445

Review 6.  Dry eye disease and microbial keratitis: is there a connection?

Authors:  Srihari Narayanan; Rachel L Redfern; William L Miller; Kelly K Nichols; Alison M McDermott
Journal:  Ocul Surf       Date:  2013-01-29       Impact factor: 5.033

7.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

8.  Group X phospholipase A2 stimulates the proliferation of colon cancer cells by producing various lipid mediators.

Authors:  Fanny Surrel; Ikram Jemel; Eric Boilard; James G Bollinger; Christine Payré; Carine M Mounier; Kati A Talvinen; Veli J O Laine; Timo J Nevalainen; Michael H Gelb; Gérard Lambeau
Journal:  Mol Pharmacol       Date:  2009-07-14       Impact factor: 4.436

9.  Synthesis of oligo(ethylene glycol) substituted phosphatidylcholines: secretory PLA2-targeted precursors of NSAID prodrugs.

Authors:  Renato Rosseto; Joseph Hajdu
Journal:  Chem Phys Lipids       Date:  2010-01       Impact factor: 3.329

10.  Longitudinal changes in tear fluid lipidome brought about by eyelid-warming treatment in a cohort of meibomian gland dysfunction.

Authors:  Sin Man Lam; Louis Tong; Xinrui Duan; U Rajendra Acharya; Jen Hong Tan; Andrea Petznick; Markus R Wenk; Guanghou Shui
Journal:  J Lipid Res       Date:  2014-07-03       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.